miR-16 and miR-26a target checkpoint kinases Wee1 and Chk1 in response to p53 activation by genotoxic stress.
about
Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosismiR-34: from bench to bedsideWee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapyInduction of Macrophage Function in Human THP-1 Cells Is Associated with Rewiring of MAPK Signaling and Activation of MAP3K7 (TAK1) Protein KinaseIdentification of a new target of miR-16, Vacuolar Protein Sorting 4a.Deep RNA sequencing reveals that microRNAs play a key role in lactation in rats.One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy.MicroRNA 26a (miR-26a)/KLF4 and CREB-C/EBPβ regulate innate immune signaling, the polarization of macrophages and the trafficking of Mycobacterium tuberculosis to lysosomes during infection.DNA damage modulates interactions between microRNAs and the 26S proteasomeMiR-138 Suppresses Cell Proliferation by Targeting Bag-1 in Gallbladder CarcinomaMini but mighty: microRNAs in the pathobiology of periodontal disease.Herpesvirus saimiri MicroRNAs Preferentially Target Host Cell Cycle Regulators.Anti-tumoral effect of desmethylclomipramine in lung cancer stem cells.Systematic analysis of the p53-related microRNAs in breast cancer revealing their essential roles in the cell cycleMutant p53 induces EZH2 expression and promotes epithelial-mesenchymal transition by disrupting p68-Drosha complex assembly and attenuating miR-26a processingmiR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathwaysMicroRNAs in Hyperglycemia Induced Endothelial Cell Dysfunction.Genome-Wide Scleral Micro- and Messenger-RNA Regulation During Myopia Development in the Mouse.Polypharmacology of small molecules targeting the ubiquitin-proteasome and ubiquitin-like systems.CHK1 regulates NF-κB signaling upon DNA damage in p53- deficient cells and associated tumor-derived microvesicles.The role of microRNA-26a in human cancer progression and clinical application.KMT Set7/9 affects genotoxic stress response via the Mdm2 axis.Anti-cancer drugs reactivate tumor suppressor miR-375 expression in tongue cancer cells.KMTase Set7/9 is a critical regulator of E2F1 activity upon genotoxic stressHuman EHMT2/G9a activates p53 through methylation-independent mechanism.Regulation of Endoribonuclease Activity of Alpha-Type Proteasome Subunits in Proerythroleukemia K562 Upon Hemin-Induced Differentiation.Effect of SMYD3 on the microRNA expression profile of MCF-7 breast cancer cells.Synaptotagmin-7 is overexpressed in hepatocellular carcinoma and regulates hepatocellular carcinoma cell proliferation via Chk1-p53 signaling.The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain.Sustained expression of miR-26a promotes chromosomal instability and tumorigenesis through regulation of CHFR.MiR-16-5p mediates a positive feedback loop in EV71-induced apoptosis and suppresses virus replication.Co-expression of RelA/p65 and ACTN4 induces apoptosis in non-small lung carcinoma cells.MYC and tumor metabolism: chicken and egg.microRNA-26a modulates inflammatory response induced by toll-like receptor 4 stimulation in microglia.microRNA-26a induces a mitochondrial apoptosis mediated by p53 through targeting to inhibit Mcl1 in human hepatocellular carcinoma.
P2860
Q26774960-1BCDFF46-7FC1-4A91-A66E-C7C1C53E6A98Q26822928-375577D4-F46F-403C-AB41-235F9A12C12CQ28833606-CE0E5A73-C559-45B7-9957-A3B191B51F39Q30386219-1B41D5DD-8F0E-4217-9671-BC3A9EC81BC3Q30411832-45340C91-4BA8-4204-93D5-7490917B1307Q31162650-6065313C-F3D8-4E3F-8909-E41002BF286FQ33618935-BC26CC2E-D0E9-4C75-A3C0-059E3F796D4EQ33783769-40A524E7-6035-47DD-B0E3-EC097B4F05C2Q33976943-79C2FA33-FBBD-42E5-8782-E8D304CACB92Q35627069-BF3BD8E7-6C25-42CB-8046-356F8479A708Q35933145-26917003-3276-4F1D-8B0F-31156AC2A674Q36208124-BBA7E747-12F5-4362-8B90-EC991BFAF60CQ36231919-88E10A4F-7B78-44F9-93C4-0872C2029F2BQ36336083-B4FE3835-04F5-4A9D-956A-0FC7BD187223Q36689074-AA925B20-8555-455B-BD6B-30A8295D8249Q36772022-0A23F3E5-8D14-4B19-A33C-7C2274CF54A3Q36847079-F06ADFF4-5508-4636-B1AC-DBA241EAA942Q37407573-B4F37581-1DD5-4AE3-81A4-208C0FF693CFQ38492748-F7625997-0B07-4567-B00F-1DBE021B9A3CQ38790651-D7E15623-B0CD-47B4-9CF0-E494710D6F03Q38796729-C7ADAA8D-D615-47D5-B26F-792C4D43013AQ38839983-183CA8F5-92E5-42DF-AF0A-B1BF4270E864Q38927441-C5D7DD35-99BB-432B-A719-5770C70B6D4EQ38965954-D93AF735-9A86-45D2-A4D4-830BA8A73EB6Q39565523-ADA30324-FE03-4A1B-9D03-6D5B7AA75388Q40218121-E0066EC0-3B6F-4C39-88FB-458408954603Q41143586-B5D4897B-6477-4519-8204-B7BF6F9C730DQ41633930-AEE188F4-DDD2-4124-8097-9E51AEF5941BQ42016261-2BC398B4-28B4-4412-963E-53E583B111A5Q42289696-E255C1DA-C50F-46FA-8E57-C8C7B54EE5CCQ45324183-198DC820-F6CA-4B49-8CA8-2D99E2DEC452Q47282395-0A3F3CA7-C83F-4C63-983D-D644B209A3CDQ47414931-DFAAB0A0-D32D-413C-A580-1D1BE018A87CQ53348983-40D2F973-F653-4876-841C-08FC19DA0CA9Q55054170-33FE40DF-55ED-4A80-BE8D-86B2EB4E6365
P2860
miR-16 and miR-26a target checkpoint kinases Wee1 and Chk1 in response to p53 activation by genotoxic stress.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
miR-16 and miR-26a target chec ...... ctivation by genotoxic stress.
@en
miR-16 and miR-26a target chec ...... ctivation by genotoxic stress.
@nl
type
label
miR-16 and miR-26a target chec ...... ctivation by genotoxic stress.
@en
miR-16 and miR-26a target chec ...... ctivation by genotoxic stress.
@nl
prefLabel
miR-16 and miR-26a target chec ...... ctivation by genotoxic stress.
@en
miR-16 and miR-26a target chec ...... ctivation by genotoxic stress.
@nl
P2093
P2860
P356
P1476
miR-16 and miR-26a target chec ...... ctivation by genotoxic stress.
@en
P2093
A V Antonov
N A Barlev
N Purmessur
V Aksenova
P2860
P2888
P356
10.1038/CDDIS.2013.483
P577
2013-12-12T00:00:00Z
P5875
P6179
1015156329